Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K3JQ
|
|||
| Former ID |
DIB014154
|
|||
| Drug Name |
RPI-MN
|
|||
| Synonyms |
Pepteron (oral, HIV), ReceptoPharm; RPI-MN (oral, HIV); RPI-MN (oral, HIV), ReceptoPharm
Click to Show/Hide
|
|||
| Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0] | Phase 1 | [1] | |
| Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 42] | Phase 1 | [2] | ||
| Company |
ReceptoPharm Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Nicotinic acetylcholine receptor (nAChR) | Target Info | Antagonist | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Highly sodium permeable acetylcholine nicotinic receptors | |||
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | ||||
| WikiPathways | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.